advertisement
11.13.4 Betablocker and prostaglandin (4)
Showing records 1 to 4
Display all abstracts in classification 11.13.4 Betablocker and prostaglandin
Search within classification 11.13.4 Betablocker and prostaglandin57529 Evaluation of the effectiveness of Ganfort treatment in patients with secondary neovascular glaucoma associated with diabetes mellitus
Vestnik Oftalmologii 2014; 130: 45-48
57052 Efficacy, safety, and tolerability of preservative-free fixed combination of tafluprost 0.0015%/timolol 0.5% versus concomitant use of the ingredients
Holló G; Hommer A; Antón López A; Ropo A
Journal of Ocular Pharmacology and Therapeutics 2014; 30: 468-475
57517 Efficacy and safety of benzalkonium chloride-free fixed-dose combination of latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension
Bhagat P; Sodimalla K; Paul C; Pandav SS; Raman GV; Ramakrishnan R; Joshi A; Raut A
Clinical Ophthalmology 2014; 8: 1241-1252
57382 24-hour efficacy of travoprost/timolol BAK-free versus latanoprost/timolol fixed combinations in patients insufficiently controlled with latanoprost
Konstas AG; Voudouragkaki IC; Boboridis KG; Haidich AB; Paschalinou E; Giannopoulos T; Dragoumis ND; Makridis AK; Kahook MY
Advances in Therapy 2014; 31: 592-603
